Coleman L M, Fowler L L, Williams M E
Program on Aging, School of Medicine, University of North Carolina, Chapel Hill 27599-7550, USA.
J Am Geriatr Soc. 1995 Jul;43(7):747-50. doi: 10.1111/j.1532-5415.1995.tb07043.x.
To describe the use of unproven therapies for Alzheimer's disease.
Descriptive survey using a written questionnaire.
101 primary caregivers of people with Alzheimer's disease who attended Alzheimer's disease support group meetings.
Fifty-five percent of caregivers reported that they had tried at least one alternative therapy to improve the patient's memory. Twenty percent of caregivers tried three or more unproven therapies. Vitamins were used most frequently (84%), and health foods (27%), herbal medicines (11%), "smart pills" (9%), and home remedies (7%) were also tried. Most caregivers reported trying the therapies in the early stage of the illness and did not notice significant improvement in the patient's memory. Twenty-five percent of caregivers had tried unproven therapies for behavior problems. There was no correlation between the use of alternative therapies and the sex of the caregiver, age of the caregiver, level of caregiver frustration, presence of problem behaviors, or perceived level of physician support.
The use of unproven therapies by people with early Alzheimer's disease is common and cannot be predicted by characteristics of the primary caregiver. Although this use may be understandable, it exposes vulnerable people to possible side effects, increased costs, and possible exploitation. Health care workers should actively inquire about the use of alternative therapies, and explore the reasons behind their use, so that they can better understand and meet the needs of their patients and their caregivers.
描述用于阿尔茨海默病的未经证实的疗法的使用情况。
使用书面问卷进行描述性调查。
101名参加阿尔茨海默病支持小组会议的阿尔茨海默病患者的主要照料者。
55%的照料者报告称他们至少尝试过一种替代疗法来改善患者的记忆力。20%的照料者尝试过三种或更多未经证实的疗法。维生素使用最为频繁(84%),还尝试过健康食品(27%)、草药(11%)、“聪明药”(9%)和家庭疗法(7%)。大多数照料者报告在疾病早期就尝试了这些疗法,但并未注意到患者记忆力有明显改善。25%的照料者曾尝试用未经证实的疗法解决行为问题。替代疗法的使用与照料者的性别、年龄、照料者的沮丧程度、是否存在问题行为或感知到的医生支持水平之间没有关联。
早期阿尔茨海默病患者使用未经证实的疗法很常见,且无法通过主要照料者的特征来预测。尽管这种使用可能可以理解,但它使易受伤害的人面临可能的副作用、成本增加以及可能被利用的风险。医护人员应积极询问替代疗法的使用情况,并探究其背后的原因,以便能更好地理解并满足患者及其照料者的需求。